Literature DB >> 29671226

LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression.

Xinzhi Liu1, Yimamu Yidayitula1, Heng Zhao1, Yi Luo1, Xiaoqiang Ma1, Minhua Xu2,3.   

Abstract

Long non-coding RNAs (lncRNAs) LINC00152 plays important roles in the progression of some tumors. However, the role of LINC00152 in human l glioblastoma is still unknown. In this study, we indicated that LINC00152 expression level was upregulated in glioblastoma tissues and cell lines. Overexpression of LINC00152 promoted the U87 and LN229 cell proliferation and invasion. Moreover, overexpression of LINC00152 suppressed the E-cadherin expression, where ectopic expression of LINC00152 promoted the N-cadherin, Vimentin, and Snail expression. These results suggested that LINC00152 enhanced epithelial-to-mesenchymal transition (EMT) program in the glioblastoma cell. Overexpression of LINC00152 suppressed the miR-107 expression in the U87 cell and enhanced the HMGA2 expression, which is a direct target gene of miR-107. In addition, we showed that the miR-107 expression was downregulated in the glioblastoma tissues and cell lines. Interesting, the expression of LINC00152 was negatively related with miR-107 expression in the glioblastoma tissues. Furthermore, LINC00152 promoted the glioblastoma cell proliferation and invasion through inhibiting miR-107 expression. These data suggested that LINC00152 acted as oncogene roles in the glioblastoma cell partly through targeting the miR-107 expression.

Entities:  

Keywords:  Glioblastoma; LINC00152; Long non-coding RNAs; miR-107

Mesh:

Substances:

Year:  2018        PMID: 29671226     DOI: 10.1007/s11356-018-1784-x

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  39 in total

1.  Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.

Authors:  Ben Yue; Donglan Cai; Chenchen Liu; Changyi Fang; Dongwang Yan
Journal:  Mol Ther       Date:  2016-09-16       Impact factor: 11.454

2.  Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.

Authors:  Ziling Huang; Lanshan Huang; Siqiao Shen; Jia Li; Huiping Lu; Weijia Mo; Yiwu Dang; Dianzhong Luo; Gang Chen; Zhenbo Feng
Journal:  Oncol Rep       Date:  2015-09-08       Impact factor: 3.906

3.  Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.

Authors:  Jiri Sana; Lenka Radova; Radek Lakomy; Leos Kren; Pavel Fadrus; Martin Smrcka; Andrej Besse; Jana Nekvindova; Marketa Hermanova; Radim Jancalek; Marek Svoboda; Marian Hajduch; Pavel Slampa; Rostislav Vyzula; Ondrej Slaby
Journal:  Carcinogenesis       Date:  2014-10-16       Impact factor: 4.944

Review 4.  CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-05-01       Impact factor: 6.831

5.  HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy.

Authors:  Wei Zhao; Shuang Dong; Bensong Duan; Ping Chen; Lei Shi; Hengjun Gao; Haizhi Qi
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

6.  microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.

Authors:  Jungeun Kim; Ying Zhang; Michael Skalski; Josie Hayes; Benjamin Kefas; David Schiff; Benjamin Purow; Sarah Parsons; Sean Lawler; Roger Abounader
Journal:  Cancer Res       Date:  2014-01-14       Impact factor: 12.701

7.  C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.

Authors:  Xiaolu He; Xueming Tan; Xiang Wang; Heiying Jin; Li Liu; Limei Ma; Hong Yu; Zhining Fan
Journal:  Tumour Biol       Date:  2014-09-04

8.  Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p.

Authors:  M-Z Ma; B-F Chu; Y Zhang; M-Z Weng; Y-Y Qin; W Gong; Z-W Quan
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

9.  miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.

Authors:  Soumya Alige Mahabala Rao; Arivazhagan Arimappamagan; Paritosh Pandey; Vani Santosh; Alangar Sathyaranjandas Hegde; Bangalore Ashwathnarayanara Chandramouli; Kumaravel Somasundaram
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.

Authors:  Er-bao Zhang; Rong Kong; Dan-dan Yin; Liang-hui You; Ming Sun; Liang Han; Tong-peng Xu; Rui Xia; Jin-song Yang; Wei De; Jin fei Chen
Journal:  Oncotarget       Date:  2014-04-30
View more
  12 in total

1.  Role of LINC00152 in non-small cell lung cancer.

Authors:  Hong Yu; Shu-Bin Li
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

2.  LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis.

Authors:  Gang Peng; Jun Su; Songhua Xiao; Qing Liu
Journal:  J Neurooncol       Date:  2021-09-03       Impact factor: 4.130

3.  LncRNA GAS8-AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation.

Authors:  Xiaoming Wu; Tingting Jiang; Rui Huang; Xue Xiao
Journal:  Brain Behav       Date:  2021-05-04       Impact factor: 2.708

4.  LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.

Authors:  Sumin Geng; Shaohua Tu; Weilun Fu; Jianbo Wang; Zhenwei Bai
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

5.  LINC01152 upregulates MAML2 expression to modulate the progression of glioblastoma multiforme via Notch signaling pathway.

Authors:  Jianheng Wu; Nannan Wang; Ying Yang; Guangyuan Jiang; Qingchun Mu; Hui Zhan; Fuyong Li
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

Review 6.  Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Guive Sharifi; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-03       Impact factor: 6.244

7.  Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children.

Authors:  Jingying Zhou; Pan Wang; Ran Zhang; Xiaokai Huang; Hanqi Dai; Li Yuan; Jichen Ruan
Journal:  Pharmgenomics Pers Med       Date:  2021-05-25

8.  Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia.

Authors:  Diego Alberto Bárcenas-López; Juan Carlos Núñez-Enríquez; Alfredo Hidalgo-Miranda; Fredy Omar Beltrán-Anaya; Didier Ismael May-Hau; Elva Jiménez-Hernández; Vilma Carolina Bekker-Méndez; Janet Flores-Lujano; Aurora Medina-Sansón; Edna Liliana Tamez-Gómez; Víctor Hugo López-García; José Ramón Lara-Ramos; Nora Nancy Núñez-Villegas; José Gabriel Peñaloza-González; Luz Victoria Flores-Villegas; Raquel Amador-Sánchez; Rosa Martha Espinosa-Elizondo; Jorge Alfonso Martín-Trejo; Martha Margarita Velázquez-Aviña; Laura Elizabeth Merino-Pasaye; María Luisa Pérez-Saldívar; David Aldebarán Duarte-Rodríguez; José Refugio Torres-Nava; Beatriz Cortés-Herrera; Karina Anastacia Solís-Labastida; Ana Itamar González-Ávila; Jessica Denisse Santillán-Juárez; Alejandra Jimena García-Velázquez; Haydee Rosas-Vargas; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Juan Manuel Mejía-Aranguré; Silvia Jiménez-Morales
Journal:  Genes (Basel)       Date:  2020-03-13       Impact factor: 4.096

9.  LncRNA LINC00152 Promotes Laryngeal Cancer Progression by Sponging MiR-613.

Authors:  Xuesong Zheng; Su Dong; Lele Sun; Jialu Xu; Jia Liu; Rui Hao
Journal:  Open Med (Wars)       Date:  2020-03-26

10.  MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression.

Authors:  Jun Zhu; WeiTing Gu; Cai Yu
Journal:  Cell Prolif       Date:  2019-10-30       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.